Literature DB >> 8667080

Metal ion speciation in blood plasma: gallium-67-citrate and MRI contrast agents.

G E Jackson1, M J Byrne.   

Abstract

UNLABELLED: Metal chelate ions are commonly used in medical diagnostic imaging as MRI contrast or imaging agents. The efficacy of these metals depends on their in vivo behavior, which in turn depends on their in vivo speciation.
METHODS: A computer model has been used to simulate the speciation of Ga3+ and Gd3+ in blood plasma. The model has been tested against known clinical data and then used to investigate Ga3+ uptake by tumor cells. The iatrogenic effect of a gadopentetic acid enhanced MRI scan upon the biodistribution of 67Ga citrate has also been calculated.
RESULTS: The speciation of Ga3+ calculated using the computer model is concordant with clinical data. The results support transferrin mediated uptake of Ga3+ by tumor cells but also account for Ga(III) biodistribution observed in hypotransferrinemic subjects. In a study of the effect of gadopentetic acid upon 67Ga gallium citrate, neither residual DTPA nor [Gd(DTPA)]2- cause significant changes in the speciation of Ga(III). The calculations show that dissociation of 4% of the administered gadopentetic acid results in the formation of a mixed, Gd(III) and Ga(III), metal transferrin complex and a 100-fold increase in the concentration of [Ga(OH)4]-.
CONCLUSION: Computer simulation is a valuable tool which can be used to explain/understand in vivo behavior of radioactive metal ions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8667080

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Incorporation of gallium-68 into the crystal structure of Prussian blue to form K(68)GaxFe1-x[Fe(CN)6] nanoparticles: toward a novel bimodal PET/MRI imaging agent.

Authors:  Murthi S Kandanapitiye; Matthew D Gott; Andrew Sharits; Silvia S Jurisson; Patrick M Woodward; Songping D Huang
Journal:  Dalton Trans       Date:  2016-05-31       Impact factor: 4.390

2.  Cyclotron production and radiochemical separation of 55Co and 58mCo from 54Fe, 58Ni and 57Fe targets.

Authors:  H F Valdovinos; R Hernandez; S Graves; P A Ellison; T E Barnhart; C P Theuer; J W Engle; W Cai; R J Nickles
Journal:  Appl Radiat Isot       Date:  2017-09-06       Impact factor: 1.513

3.  Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models.

Authors:  Yan Huo; Lei Kang; Xiaoxi Pang; Haoyuan Shen; Ping Yan; Chunli Zhang; Xuhe Liao; Xueqi Chen; Rongfu Wang
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

4.  Importance of the biofilm matrix for the erosion stability of Bacillus subtilis NCIB 3610 biofilms.

Authors:  M Klotz; M Kretschmer; A Goetz; S Ezendam; O Lieleg; M Opitz
Journal:  RSC Adv       Date:  2019-04-11       Impact factor: 4.036

5.  Development of Peptoid-Based Ligands for the Removal of Cadmium from Biological Media.

Authors:  Abigail S Knight; Effie Y Zhou; Matthew B Francis
Journal:  Chem Sci       Date:  2015-05-14       Impact factor: 9.825

6.  Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.

Authors:  Maria Iris Tsionou; Caroline E Knapp; Calum A Foley; Catherine R Munteanu; Andrew Cakebread; Cinzia Imberti; Thomas R Eykyn; Jennifer D Young; Brett M Paterson; Philip J Blower; Michelle T Ma
Journal:  RSC Adv       Date:  2017-10-25       Impact factor: 3.361

Review 7.  Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.

Authors:  Ruslan Cusnir; Cinzia Imberti; Robert C Hider; Philip J Blower; Michelle T Ma
Journal:  Int J Mol Sci       Date:  2017-01-08       Impact factor: 5.923

8.  Non-toxic Polymeric Dots with the Strong Protein-Driven Enhancement of One- and Two-Photon Excited Emission for Sensitive and Non-destructive Albumin Sensing.

Authors:  Sebastian G Mucha; Marta Piksa; Lucyna Firlej; Agnieszka Krystyniak; Mirosława O Różycka; Wioletta Kazana; Krzysztof J Pawlik; Marek Samoć; Katarzyna Matczyszyn
Journal:  ACS Appl Mater Interfaces       Date:  2022-08-26       Impact factor: 10.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.